AFP and hepatocellular carcinoma: Meanwhile, we introduced edge-based biomarkers with differential correlation/network information instead of traditional differential gene/protein expression information to build the prediction model, which demonstrated that the edge panel had better performances in both the diagnosis and prognosis in terms of both precision and specificity for HCC, especially for patients with AFP-negative HCC, than individual genes and gene pairs as well as the vertex panel.